EndoTODAY | EndoATLAS | ¿Ü·¡¼³¸íÀÚ·á
±â»ýÃæ | ½Äµµ | À§ | À§¾Ï | ESD | õ±â´©¼³
Home | Guide | ÁÖÀÎÀå | ±¸µ¶ | °Ë»ö | ¸µÅ©
±¤ÁÖ Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ´öÀçȦ¿¡¼ ¿¸° ³»½Ã°æÇÐȸ Áý´ãȸ¿¡ ´Ù³à¿Ô½À´Ï´Ù. Á¦ÁÖ´ëÇб³ º´¿ø°ú teleconference·Î ¿¬°áµÇ¾î ´õ¿í Èï¹Ì·Î¿ü½À´Ï´Ù.
Àü³²´ëÇб³ À¯Á¾¼± ±³¼ö´Ô Àλ縻¾¸
±¤ÁÖ´Â Á¦ °íÇâÀÔ´Ï´Ù. ´õ¿í Áñ°Å¿ü½À´Ï´Ù.
´ÙÀ½ ³¯ ¾Æħ ÇмúÀ§¿øȸ ¿öÅ©¼¥ÀÌ ÀÖ¾ú½À´Ï´Ù. ÇÐȸ¹ßÀü¹æÇâ¿¡ ´ëÇÑ ³íÀǸ¦ ÇÏ¿´½À´Ï´Ù.
1. Gastric inflammatory fibrinoid polyp. Á¦ÁÖ´ëÇб³ ³ª¼ö¿µ
ÀüÁ¤ºÎ »óÇÇÇÏ Á¾¾ç ¾ç»óÀÇ inflammatory fibrinoid polyp 2¿¹°¡ ¼Ò°³µÇ¾ú½À´Ï´Ù.
c-kit À½¼º, s-100 À½¼º, CD34 ¾ç¼ºÀÌ ºñ±³Àû ƯÀÌÇÑ ¼Ò°ßÀ̶ó°í ÇÕ´Ï´Ù.
EndoTODAY¿¡¼ ¿Å±é´Ï´Ù.
Inflammatory fibrinoid polypÀº gastric submucosal granuloma with eosinophilic infiltration, eosinophilic granuloma, hemangiopericytoma, fibroma, inflammatory pseudotumor µî ´Ù¾çÇÑ À̸§À¸·Î ºÒ·È´ø Á¾¾çÀÔ´Ï´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¼¶À¯Á¶Á÷, Ç÷°ü, È£»ê±¸¸¦ Æ÷ÇÔÇÑ ¸¹Àº ¿°Áõ¼¼Æ÷µé·Î ±¸¼ºµÇ¾î ÀÖ°í ±¹¼ÒÀûÀÎ ºñ½Å»ý¼º ¼ºÀåÀ» ÇÏ´Â ÁúȯÀÔ´Ï´Ù. ÁÖ·Î À§¿¡ ¹ß»ýÇÏÁö¸¸ µå¹°°Ô ¼ÒÀå, ´ëÀå, ½Äµµ¿¡¼µµ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾Ç¼ºº¯È´Â º¸°íµÈ ¹Ù ¾ø½À´Ï´Ù. À§³»½Ã°æ¿¡¼´Â ÁÖ·Î pedunculated polypÀÇ ÇüÅ°¡ ¸¹Àºµ¥ SMT¿Í ºñ½ÁÇÏ°Ô º¸ÀÌ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù. ÀÌ Áõ·Ê´Â SMTó·³ º¸¿´´ø °æ¿ìÀÌ°í wedge resectionÀ¸·Î È®ÁøÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù. ¼ö¼úÀü impressionÀº GIST¿´½À´Ï´Ù.
Inflammatory fibrinoid polyp
* Âü°í: EndoTODAY À§¿ëÁ¾
2. »óºÎ½Äµµ¿¡¼ ¹ß°ßµÈ 12cmÀÇ ³¶¼º Á¾¾ç. ºÎ»ê´ëº´¿ø À̹®¿ø
6-7°³¿ù ÀüºÎÅÍ ½ÃÀÛµÈ »óºÎ½Äµµ À̹°°¨À¸·Î À̺ñÀÎÈÄ°ú Áø·á¸¦ ÇÏ¿´À¸³ª ƯÀ̼ҰßÀÌ ¾ø¾î ³»½Ã°æÀ» ½ÃÇàÇÏ¿´½À´Ï´Ù. »óºÎ½Äµµ UES Á÷ÇϺο¡¼ ±â½ÃÇÑ intraluminal growth¸¦ º¸ÀÌ´Â 12 cm Á¾±«¿´°í ³»½Ã°æÀ» ȸ¼öÇÒ ¶§ Á¾¾çÀÌ ±¸° ³»·Î herniationÀ» º¸¿´½À´Ï´Ù. Snare polypectomy¸¦ ÇÏ¿´½À´Ï´Ù. º´¸®°á°ú´Â giant fibrovascular polypÀ̾ú½À´Ï´Ù.
±è±¤ÇÏ ±³¼ö´ÔÀº fibrovascular polypÀº EUS¿¡¼ lipoma ºñ½ÁÇÏ°Ô º¸ÀÌÁö¸¸ »ö±òÀÌ ³ë¶þÁö ¾Ê´Ù´Â Á¡À¸·Î ±¸ºÐÇÒ ¼ö ÀÖ´Ù, EUS¿¡¼ stalk ¹× vesselÀÇ ±½±â¸¦ ÃøÁ¤ÇÏ´Â °ÍÀÌ ÃâÇ÷ À§ÇèÀ» ¿¹ÃøÇÒ ¼ö ÀÖ´Ù°í ¸»¾¸Çϼ̽À´Ï´Ù.
Â÷º´¿ø Á¶ÁÖ¿µ ±³¼ö´ÔÀº ÃâÇ÷¿¡ ´ëÇÑ ´ëºñ¸¦ Àß ÇØ¾ß ÇÑ´Ù, detachable snare¸¦ 2°³ Á¤µµ ÀåÂøÇÏ°í 30ºÐ ÈÄ ½Ã¼úÇÏ¸é ¾ÈÀüÇÏ´Ù°í comment Çϼ̽À´Ï´Ù.
3. Hiatal hernia with recurrent UGI bleeding. »ï¼º¼¿ïº´¿ø À§Áø¿ì
½ÉÇÑ hiatal hernia°¡ ÀÖ´ø ºÐÀÌ Cameron ulcer·Î ÀÎÇÑ ¹Ýº¹ÃâÇ÷À» º¸¿´°í PPI¸¦ ÀÌ¿ëÇÏ¿© ÃâÇ÷À» ¸·±âÀ§ÇÑ ³ë·ÂÀÌ ½ÇÆÐÇÏ¿© °á±¹ hernia reduction ¼ö¼úÀ» ¹Þ¾Ò½À´Ï´Ù.
Cameron ulcer¿Í hiatal hernia. PDF 3.7M - Case Reviews in Gastroenterology
* Âü°í: EndoTODAY hiatal hernia
4. À§½Äµµ¿ª·ùÁúȯ¿¡¼ Ç׿ª·ù³»½Ã°æ¼ö¼ú (ARES). ºÐ´çÂ÷º´¿ø ¼Û°¡¿ø
Alcoholic cirrhosis ȯÀÚ·Î DeMeester score´Â 47.4¿´½À´Ï´Ù. EG junction Á¡¸·ÀÇ 3/4 Á¤µµ¸¦ EMR-C ¹æ¹ýÀ¸·Î Á¦°Å(ARES) ÈÄ ÇöÀúÇÑ È£ÀüµÇ¾ú½À´Ï´Ù.
Â÷º´¿ø¿¡¼´Â ÃÖ±Ù±îÁö ARES 11¿¹¸¦ ½ÃÇàÇÏ¿´´Ù°í ÇÕ´Ï´Ù. ARES´Â artificialÇÏ°Ô stricture¸¦ ¸¸µå´Â ½Ã¼úÀ̹ǷΠ½Ã¼ú ÈÄ ¹Ýµå½Ã dz¼±È®Àå¼úÀÌ ÇÊ¿äÇÕ´Ï´Ù. dz¼±È®Àå¼úÀÌ ¿©·¯¹ø ÇÊ¿äÇÑ °æ¿ìµµ ÀÖ½À´Ï´Ù. Á¶ÁÖ¿µ ±³¼ö´Ô²²¼´Â laparoscopic fundoplicationÀ» ´ëÄ¡ÇÒ ¼ö ÀÖ´Â ÁÁÀº ½Ã¼úÀ̶ó°í comment Çϼ̽À´Ï´Ù.
ÀüÈÆÀç ¼±»ý´Ô²²¼´Â Stretta´Â indicationÀ» Àß ÀâÀ¸¸é 80% Á¤µµ È¿°ú°¡ ÀÖÁö¸¸ PPI response°¡ ¾ø´Ù°í ¸¶±¸ ½ÃÇàÇϸé 50% Á¤µµ¹Û¿¡ È¿°ú°¡ ¾øÀ» ¼ö ÀÖ´Ù°í comment Çϼ̽À´Ï´Ù.
* Âü°í: EndoTODAY Stretta
5. Isolated myeloid sarcoma. ÇѾç´ëº´¿ø ÀÌÁö¿µ
üÁß°¨¼Ò¸¦ º¸ÀÎ 55¼¼ ³²ÀÚ¿´°í CT¿¡¼ ¿ìÇϺ¹ºÎÀÇ Á¾±«°¡ ÀÖ¾ú°í ´ëÀå³»½Ã°æ¿¡¼ A colonÀÇ Å« Á¾±«°¡ ÀÖ¾ú½À´Ï´Ù. Á¶Á÷°Ë»ç¿¡¼ myeoloid °èÅëÀÎÁö lymphoma ÂÊÀÎÁö ¸íÈ®ÇÏÁö ¾ÊÀº »óÅ¿¡¼ obstructionÀ» ÇØ°áÇϱâ À§ÇÏ¿© ¼ö¼úÀ» ÇÏ¿´°í ÃÖÁ¾ÀûÀ¸·Î isolated myeloid sarcoma·Î Áø´ÜµÇ¾ú½À´Ï´Ù.
Àü³²ÀÇ´ë º´¸®°ú ¼±»ý´Ô²²¼´Â myeloid massÀÇ °æ¿ì H&E ¼Ò°ß¸¸À¸·Î Áø´ÜÇϱ⠾î·Æ°í immunohistochemistry°¡ Áß¿äÇÏ´Ù°í comment ÇÏ¿´½À´Ï´Ù.
Àü³²ÀÇ´ë ¿µ»óÀÇÇаú ¼±»ý´Ô²²¼´Â »çÁø¿¡¼ lymphomaÀÇ °¡´É¼ºÀº ¶³¾îÁø´Ù°í Çϼ̽À´Ï´Ù. Lymphoma´Â enhancement°¡ Àß µÇÁö ¾Ê±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ Áõ·Ê´Â enhance°¡ Àß µÇ°í ÀÖÀ¸¹Ç·Î neuroendocrine tumor µîÀ» ¸ÕÀú °¨º°ÇØ¾ß ÇÒ °Í °°´Ù°í comment ÇÏ¿´½À´Ï´Ù.
6. Gastric plasmacytoma as the primary presentation in multiple myeloma. Á¶¼±´ëÇб³ Á¤À±
7. ºñ¸¸ ³»½Ã°æÄ¡·á ÈÄ ¹ß»ýÇÑ À§±Ë¾ç õ°ø. °í·Á´ëÇб³ ¾È¾Ïº´¿ø À¯Àΰæ
7ÁÖ Àü ´ÙÀ̾îÆ®¸¦ ¸ñÀûÀ¸·Î À§³»Ç³¼±»ðÀÔ¼ú ÈÄ º¹ÅëÀ¸·Î ³»¿øÇÑ ¿©¼ºÀ̾ú½À´Ï´Ù. ½Äµµ ÀüÁ¤ºÎ¿¡ balloonÀÌ ÀÖ¾ú°í Àüº® õ°ø°ú peumoperitoneumÀ¸·Î ¼ö¼úÀ» ÇÏ¿´½À´Ï´Ù.
¼ö¼ú ½Ã õ°øÀÇ ±¸¸ÛÀº À۾Ƽ balloonÀº ³²°ÜµÎ¾ú°í ¼ö¼ú ¸î ÀÏ ÈÄ ³»½Ã°æÀ¸·Î balloonÀ» Á¦°ÅÇÏ¿´½À´Ï´Ù. dz¼± ½Ã¼ú ÈÄ PPI º¹¿ëÀ» ÀÚÀÇ·Î Áß´ÜÇÑ °ÍÀÌ Ãµ°ø ¹ß»ýÀÇ Áß¿ä ¿øÀÎÀ¸·Î ³íÀǵǾú½À´Ï´Ù.
Àú´Â "CT »çÁøÀ» º¸´Ï ±×¸® ½ÉÇÑ ºñ¸¸Àº ¾Æ´Ï´øµ¥ ³»½Ã°æÄ¡·áÀÇ ÀûÀÀÁõÀ̾ú´ø °Ô ¸Â½À´Ï±î?"¶ó°í Áú¹®À» ÇÏ¿´½À´Ï´Ù. ºñ¸¸ÀÌ Áúº´ÀÎ °ÍÀº ¸Â½À´Ï´Ù. ±×·¯³ª ºñ¸¸¿¡ ´ëÇÑ ¼ö¼úÀ̳ª ³»½Ã°æÄ¡·á´Â ¾ÆÁÖ ½ÉÇÑ ºñ¸¸ ȯÀÚ¿¡¼¸¸ ½ÃÇàµÇ¾î¾ß ÇÕ´Ï´Ù. ´Ü¼øÇÑ ¹Ì¿ë ¸ñÀûÀÇ ºñ¸¸ ¼ö¼ú°ú ³»½Ã°æÄ¡·á´Â ½ÅÇØö »ç¸Á »ç°í¿Í °°Àº ¶Ç ´Ù¸¥ ºñ±ØÀ» °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ºñ¸¸Ä¡·á ³²¹ßÇÏÁö ¸¿½Ã´Ù.
* Âü°í: EndoTODAY ºñ¸¸
8. Endoscopically unresectable multiple neuroendocrine tumor (MEN syndrome I). Àü³²´ëÇб³ ¼Òȱ⳻°ú Á¶±Ô¸¸
Ca 11.8, P 2.1
MEN I À¸·Î ÆÇ´ÜÇÏ°í workupÇÏ¿´´Ù°í ÇÕ´Ï´Ù.
1) ³»½Ã°æÇÐȸ ÇмúÇà»ç on-line Áß°è
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà